Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV004724578 | SCV005336270 | likely pathogenic | TTN-related disorder | 2024-04-29 | no assertion criteria provided | clinical testing | The TTN c.55161_55164dupTCTG variant is predicted to result in a frameshift and premature protein termination (p.Val18389Serfs*4). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. This variant is located in the A-band region of the protein in which truncating TTN variants have been found more frequently in dilated cardiomyopathy patients than in controls (Herman et al. 2012. PubMed ID: 22335739). RNAseq studies from heart tissue indicate this exon is commonly included in TTN mRNA transcripts (PSI of 90%-100%); however, this analysis in muscle tissue was not performed (Roberts et al. 2015. PMID: 25589632; https://cardiodb.org/titin/titin_transcripts.php). TTN truncating variants are reported in 1-2% of presumably healthy individuals and occur more frequently in exons with low PSI values, indicating this variant is more likely to be disease causing (Herman et al. 2012. PMID: 22335739; Roberts et al. 2015. PMID: 25589632). In summary, this variant is interpreted as likely pathogenic for both autosomal dominant and autosomal recessive TTN-related disorders. |